Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
983135 Nebraska Medical Center
Dep Of Pathology, Unmc
Omaha, NE 68198Phone+1 402-559-7674Fax+1 402-559-6018
Education & Training
University of Nebraska Medical Center College of MedicineResidency, Pathology-Anatomic and Clinical, 2010 - 2014
Beijing Medical UniversityClass of 1997
Certifications & Licensure
CA State Medical License 2017 - 2025
FL State Medical License 2016 - 2018
MN State Medical License 2014 - 2017
NE State Medical License 2013 - 2014- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Clinical Trials
- A Study of HTD1801 in Healthy Subjects Start of enrollment: 2017 Mar 24
- China Antihypertensive Trial in Acute Ischemic Stroke II Start of enrollment: 2018 Jun 13
Publications & Presentations
PubMed
- Association of blood pressure and outcomes differs upon cerebral perfusion post-thrombectomy in patients with acute ischemic stroke.Jinjie Liu, Ximing Nie, Zhe Zhang, Wanying Duan, Xin Liu
Journal of Neurointerventional Surgery. 2025-01-25 - 1 citationsPrediction of futile recanalisation after endovascular treatment in acute ischaemic stroke: development and validation of a hybrid machine learning model.Ximing Nie, Jinxu Yang, Xinxin Li, Tianming Zhan, Dongdong Liu
Stroke and Vascular Neurology. 2024-12-30 - 6 citationsSmall vessel disease burden may not portend unfavorable outcome after thrombectomy for acute large vessel occlusion.Lina Zheng, Xinyi Leng, Ximing Nie, Hongyi Yan, Xuan Tian
European Radiology. 2022-11-01
Press Mentions
Similar Effect of Early, Late BP Reduction in Stroke: CATIS-2February 17th, 2023- Similar Effect of Early, Late BP Reduction in Stroke: CATIS-2February 15th, 2023
- HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (The CENTRICITY Study)January 11th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
